Washington, DC – November 14, 2011 The American Association for Clinical Chemistry (AACC) announces a major program of 12 webinars for 2012: High-Value Tests for High-Impact Diseases, which wil address four common health conditions, cardiac, diabetes, kidney, and thyroid, in three webinars each.
January 10 Analytical and Clinical Issues Regarding Contemporary and High Sensitivity TNI Assays presented by Fred Apple, PhD, Medical Director of Clinical Laboratories, Hennepin County Medical Center, Minneapolis, and Professor of Laboratory Medicine & Pathology, University of Minnesota School of Medicine, Minneapolis, MN.
February 14 Biomarkers of Heart Failure: Current Status and Future Promise presented by Robert Christenson, PhD, Director, Clinical Chemistry Laboratories, Professor of Pathology & Medical and Research Technology, University of Maryland, Baltimore, MD
March 13 The Role of Biomarkers of Inflammation in Cardiovascular Disease presented by Paul Ridker, MD, Director, Center for Cardiovascular Disease Prevention; Eugene Braunwald Professor of Medicine, Harvard Medical School, Cambridge, MA
April 10 The Pros and Cons of Using HbA1c for Diabetes Diagnosis presented by David Sacks, MB ChB, FACP, Senior Investigator and Chief of the Clinical Chemistry Service, Department of Laboratory Medicine, the National Institutes of Health, Bethesda, MD
May 8 Glucose Meter Accuracy and Glycemic Control: How Good is Good Enough? presented by Brad S. Karon, MD, PhD, Director of Point-of-Care Testing and Hospital Clinical Laboratories and Associate Professor of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
June 12 New Recommendations for Diagnosis of Hyperglycemia in Pregnancy presented by Donald Coustan, MD, Professor of Obstetrics & Gynecology, Warren Alpert Medical School of Brown University, Division of Maternal-Fetal Medicine, Women & Infants Hospital of Rhode Island, Providence.
KIDNEY DISEASE & ACUTE KIDNEY INJURY
July 10 Biomarkers for CKD: Glomerular Filtration and Progression of Kidney Disease presented by R. Neil Dalton, MA, PhD, Professor of Paediatric Biochemistry, King's College, London, UK
August 14 Biomarkers for CKD: Urine Albumin and Multi-markers presented by W. Greg Miller, PhD, DABCC, FACB, Professor of Pathology, Virginia Commonwealth University, Richmond, VA. Dr. Miller is AACC’s 2011 President-Elect and will assume the presidency on January 1, 2012.
September 11 Biomarkers for Acute Kidney Injury: Now and the Future presented by Anne Dawnay, PhD, FRCPath, Consultant Biochemist, University College London Hospitals, London, UK
October 9 Perspectives in Thyroid Testing: Pros and Cons of Immunoassay and Mass Spectrometry presented by Steven J. Soldin, PhD, Senior Scientist, National Institutes of Health, Bethesda, MD
November 13 Effective Laboratory Testing for Thyroid Health During Pregnancy presented by Jacqueline Jonklaas, MD, PhD, MPH, Associate Professor of Endocrinology & Metabolism, Georgetown University Medical Center, Washington, DC
December 11 Role of Clinical Lab Testing in Diagnosis and Management of Thyroid Cancer presented by Kenneth D. Burman, MD, Chief, Endocrine Section, Department of Medicine, Washington Hospital Center, Washington, DC
The cost of treating these chronic conditions can be significantly reduced if clinicians can detect them early through laboratory testing. This new program from AACC explores best practices for lab testing in these high-impact diseases so that the laboratory can play a greater role in improving patient outcomes and reducing costs. The webinars can be purchased from AACC as the complete series of 12, by disease in a set of three, or individually.
AACC invites interested journalists to participate in any or all of the webinars in this important new series. To register, complete and submit a Press Registration Form. For more information about these webinars or AACC, contact Peter Patterson or on either of the above phone numbers.